Harvard Bioscience, Inc. (HBIO) vs QT Imaging Holdings, Inc. (QTI)

A side-by-side comparison of Harvard Bioscience, Inc. and QT Imaging Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

HBIO

Harvard Bioscience, Inc.

$39M

$8.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

QTI

QT Imaging Holdings, Inc.

$36M

$2.58HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — HBIO vs QTI

growth of $100 · dividends reinvested · last 3y

HBIO -80.5% (-42.1%/yr)QTI +93.3% (+24.6%/yr)QTI compounded faster over this window

Log scale — wide-divergence pair

HBIO QTI

HBIO vs QTI: by the numbers

•HBIO is the larger company ($39M vs $36M market cap).
•Both run net losses; HBIO's is the smaller (-11.86% vs -65.31% net margin).

Metrics side by side

Valuation

Metric	HBIO	QTI
P/S ratio	0.44	1.26
P/B ratio	5.20	15.82
EV / EBITDA	10.54	N/A

Profitability

Metric	HBIO	QTI
Gross margin	58.16%	39.56%
Operating margin	1.17%	-17.45%
Net margin	-11.86%	-65.31%
ROE	-140.36%	-819.34%
ROIC	1.99%	-22.79%

Growth (annualized)

Metric	HBIO	QTI
Revenue CAGR (5Y)	-4.62%	N/A
Total return CAGR (5Y)	-34.33%	N/A

Go deeper

Full HBIO analysis Full QTI analysis Interactive comparison tool

Dig into the metrics

Harvard Bioscience ROE QT Imaging ROE Harvard Bioscience operating margin QT Imaging operating margin Harvard Bioscience revenue growth QT Imaging revenue growth Harvard Bioscience free cash flow QT Imaging free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.